The Role of Radiotherapy After Pleurectomy/Decortication for Malignant Pleural Mesothelioma: State of the Art
Journal of Personalized Medicine · 01.12.2025 · 15 (12) · 585
DOI: 10.3390/jpm15120585 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Personalized Medicine, online erschienen am 01.12.2025. Verfasst von Marco Andolfi und 2 weiteren Autor:innen. Beteiligte Einrichtung: Thoracic Surgery Unit, AOU (Azienda Ospedaliera Universitaria) of Marche, 60126 Ancona, Italy. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Considering the increased need to deliver adjuvant radiotherapy (RT) after pleurectomy/decortication (P/D) for malignant pleural mesothelioma (MPM) without exceeding the tolerance of the adjacent normal tissue, new advanced RT technologies have been developed. However, radiation to the whole hemithorax presents a challenge because of the increased risk of toxicity occurring with two intact radiosensitive lungs. The aim of this study is to systematically review the literature in order to assess the role of radiotherapy after P/D for MPM, based on the evidence published so far.
Methods
We conducted this systematic review according to PRISMA guidelines and registered in an international public register of systematic review (PROSPERO). A PubMed and Cochrane database search was performed to identify articles published from 2005 to 2024 regarding the role of adjuvant radiotherapy after P/D for MPM. We included only level I–III-evidence studies according to the Oxford Centre for Evidence-Based Medicine’s guidance.
Results
We selected 11 level II studies. Based on published reports, delivery of high-dose external beam ‘conventional’ RT to the entire hemithorax is not recommended in a P/D setting and hemithoracic intensity-modulated radiotherapy (IMRT) may be considered an encouraging and reasonable therapeutic option, leading to excellent loco-regional control and survival results.
Conclusions
Data and experience strongly support that the ideal platform to define potential indication of the adjuvant RT is a multidisciplinary team. Moreover, given the technical difficulty of IMRT treatment, we recommend considering this treatment in experienced centers with dedicated protocols for MPM due to their ability to detect and manage side effects resulting from the disease and the treatment as well as to ensure the best and the latest treatment plan for each patient.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Thoracic Surgery Unit, AOU (Azienda Ospedaliera Universitaria) of Marche, 60126 Ancona, Italy.
ORCID-Profile: Marco Andolfi, Michele Salati
Zitieren
APA
Andolfi, M., Salati, M., & Refai, M. (2025). The Role of Radiotherapy After Pleurectomy/Decortication for Malignant Pleural Mesothelioma: State of the Art. Journal of Personalized Medicine, 15(12), 585. https://doi.org/10.3390/jpm15120585
Vancouver
Andolfi M, Salati M, Refai M. The Role of Radiotherapy After Pleurectomy/Decortication for Malignant Pleural Mesothelioma: State of the Art. Journal of Personalized Medicine. 2025;15(12):585. doi:10.3390/jpm15120585
BibTeX
@article{Andolfi2025,
author = {Andolfi, Marco and Salati, Michele and Refai, Majed},
title = {The Role of Radiotherapy After Pleurectomy/Decortication for Malignant Pleural Mesothelioma: State of the Art},
journal = {Journal of Personalized Medicine},
year = {2025},
volume = {15},
number = {12},
pages = {585},
doi = {10.3390/jpm15120585}
}
EUVIMED